171 related articles for article (PubMed ID: 28870211)
1. Re-irradiation for oligo-recurrence from esophageal cancer with radiotherapy history: a multi-institutional study.
Jingu K; Niibe Y; Yamashita H; Katsui K; Matsumoto T; Nishina T; Terahara A
Radiat Oncol; 2017 Sep; 12(1):146. PubMed ID: 28870211
[TBL] [Abstract][Full Text] [Related]
2. Evaluating the optimal re-irradiation dose for locally recurrent esophageal squamous cell carcinoma after definitive radiotherapy.
Xu X; Wang Z; Jiang S; Shang Y; Wu Y
Radiat Oncol; 2019 Nov; 14(1):191. PubMed ID: 31684983
[TBL] [Abstract][Full Text] [Related]
3. Definitive salvage radiation therapy and chemoradiation therapy for lymph node oligo-recurrence of esophageal cancer: a Japanese multi-institutional study of 237 patients.
Yamashita H; Jingu K; Niibe Y; Katsui K; Matsumoto T; Nishina T; Terahara A
Radiat Oncol; 2017 Feb; 12(1):38. PubMed ID: 28219406
[TBL] [Abstract][Full Text] [Related]
4. A re-irradiation dose of 55-60 Gy improves the survival rate of patients with local recurrent esophageal squamous cell carcinoma after radiotherapy.
Wu X; Hu X; Chen J; He L
Radiat Oncol; 2021 Jun; 16(1):100. PubMed ID: 34103059
[TBL] [Abstract][Full Text] [Related]
5. Clinical Outcomes and Prognostic Factors of Patients With Esophageal Squamous Cell Carcinoma With Oligo-recurrence Treated With Radical Re-irradiation.
Lin CY; Fang HY; Lein MY; Lin CC; Bai LY; Tsai MH; Chen CC; Hsieh TC; Wang YC; Liang JA; Li CC; Chien CR
Anticancer Res; 2020 Apr; 40(4):2387-2392. PubMed ID: 32234942
[TBL] [Abstract][Full Text] [Related]
6. Salvage prostate re-irradiation using high-dose-rate brachytherapy or focal stereotactic body radiotherapy for local recurrence after definitive radiation therapy.
Mbeutcha A; Chauveinc L; Bondiau PY; Chand ME; Durand M; Chevallier D; Amiel J; Kee DL; Hannoun-Lévi JM
Radiat Oncol; 2017 Mar; 12(1):49. PubMed ID: 28274241
[TBL] [Abstract][Full Text] [Related]
7. Survival benefit of re-irradiation in esophageal Cancer patients with Locoregional recurrence: a propensity score-matched analysis.
Hong L; Huang YX; Zhuang QY; Zhang XQ; Tang LR; Du KX; Lin XY; Zheng BH; Cai SL; Wu JX; Li JL
Radiat Oncol; 2018 Sep; 13(1):171. PubMed ID: 30201005
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors, patterns of recurrence and toxicity for patients with esophageal cancer undergoing definitive radiotherapy or chemo-radiotherapy.
Haefner MF; Lang K; Krug D; Koerber SA; Uhlmann L; Kieser M; Debus J; Sterzing F
J Radiat Res; 2015 Jul; 56(4):742-9. PubMed ID: 25907360
[TBL] [Abstract][Full Text] [Related]
9. Clinical Impact of Re-irradiation with Carbon-ion Radiotherapy for Lymph Node Recurrence of Gynecological Cancers.
Shiba S; Okonogi N; Kato S; Wakatsuki M; Kobayashi D; Kiyohara H; Ohno T; Karasawa K; Nakano T; Kamada T
Anticancer Res; 2017 Oct; 37(10):5577-5583. PubMed ID: 28982873
[TBL] [Abstract][Full Text] [Related]
10. Salvage Carbon-ion Radiotherapy for Isolated Lymph Node Recurrence Following Curative Resection of Esophageal Cancer.
Isozaki Y; Yasuda S; Akutsu Y; Shimada H; Okazumi S; Nabeya Y; Hoshino I; Murakami K; Ebner DK; Tsuji H; Kamada T; Yamada S; Matsubara H
Anticancer Res; 2018 Nov; 38(11):6453-6458. PubMed ID: 30396971
[TBL] [Abstract][Full Text] [Related]
11. Re-irradiation stereotactic body radiotherapy for spinal metastases: a multi-institutional outcome analysis.
Hashmi A; Guckenberger M; Kersh R; Gerszten PC; Mantel F; Grills IS; Flickinger JC; Shin JH; Fahim DK; Winey B; Oh K; John Cho BC; Létourneau D; Sheehan J; Sahgal A
J Neurosurg Spine; 2016 Nov; 25(5):646-653. PubMed ID: 27341054
[TBL] [Abstract][Full Text] [Related]
12. Carbon-ion radiotherapy for lymph node oligo-recurrence: a multi-institutional study by the Japan Carbon-Ion Radiation Oncology Study Group (J-CROS).
Okonogi N; Kaminuma T; Okimoto T; Shinoto M; Yamamoto N; Yamada S; Murata K; Ohno T; Shioyama Y; Tsuji H; Nakano T; Kamada T
Int J Clin Oncol; 2019 Sep; 24(9):1143-1150. PubMed ID: 30968270
[TBL] [Abstract][Full Text] [Related]
13. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
14. Concurrent erlotinib and radiotherapy for chemoradiotherapy-intolerant esophageal squamous cell carcinoma patients: results of a pilot study.
Zhai Y; Hui Z; Wang J; Zou S; Liang J; Wang X; Lv J; Chen B; Zhu H; Wang L
Dis Esophagus; 2013 Jul; 26(5):503-9. PubMed ID: 22862289
[TBL] [Abstract][Full Text] [Related]
15. [Randomized clinical study of surgery versus radiotherapy alone in the treatment of resectable esophageal cancer in the chest].
Sun XD; Yu JM; Fan XL; Ren RM; Li MH; Zhang GL
Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):784-7. PubMed ID: 17366797
[TBL] [Abstract][Full Text] [Related]
16. Patterns of failure associated with involved field radiotherapy in patients with clinical stage I thoracic esophageal cancer.
Kawaguchi Y; Nishiyama K; Miyagi K; Suzuki O; Ito Y; Nakamura S
Jpn J Clin Oncol; 2011 Aug; 41(8):1007-12. PubMed ID: 21665908
[TBL] [Abstract][Full Text] [Related]
17. Treatment outcomes of radiotherapy for patients with stage I esophageal cancer: a single institute experience.
Sasaki T; Nakamura K; Shioyama Y; Toh Y; Okamura K; Ohura H; Hirata H; Honda H
Am J Clin Oncol; 2007 Oct; 30(5):514-9. PubMed ID: 17921713
[TBL] [Abstract][Full Text] [Related]
18. [Radiochemotherapy for esophageal cancer: which nodes should be irradiated?].
Créhange G; Quivrin M; Vulquin N; Serre AA; Maingon P
Cancer Radiother; 2014 Oct; 18(5-6):577-82. PubMed ID: 25201634
[TBL] [Abstract][Full Text] [Related]
19. Local field radiotherapy without elective nodal irradiation for postoperative loco-regional recurrence of esophageal cancer.
Kimoto T; Yamazaki H; Suzuki G; Aibe N; Masui K; Tatekawa K; Sasaki N; Fujiwara H; Shiozaki A; Konishi H; Nakamura S; Yamada K
Jpn J Clin Oncol; 2017 Sep; 47(9):809-814. PubMed ID: 28903531
[TBL] [Abstract][Full Text] [Related]
20. Re-irradiation for locally recurrent refractory breast cancer.
Merino T; Tran WT; Czarnota GJ
Oncotarget; 2015 Oct; 6(33):35051-62. PubMed ID: 26459388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
